Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Haemonetics's ebitda for the twelve months ending Sep 26, 2026 was $286.52M, down 19.7% year over year. For fiscal 2026 it was $268.45M, down 20.4% from the year before. Over ten years it grew 19.3% a year on average. The highest annual figure on record is $337.40M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $268.45M | -20.4% |
| FY2025 | Mar 29, 2025 | $337.40M | +28.7% |
| FY2024 | Mar 30, 2024 | $262.10M | +5.1% |
| FY2023 | Apr 1, 2023 | $249.34M | +39.7% |
| FY2022 | Apr 2, 2022 | $178.50M | +2.6% |
| FY2021 | Apr 3, 2021 | $174.03M | -18.5% |
| FY2020 | Mar 28, 2020 | $213.64M | +10.7% |
| FY2019 | Mar 30, 2019 | $192.96M | +32.7% |
| FY2018 | Mar 31, 2018 | $145.40M | +106.7% |
| FY2017 | Apr 1, 2017 | $70.35M | +53.0% |
| FY2016 | Apr 2, 2016 | $45.97M | -63.7% |
| FY2015 | Mar 28, 2015 | $126.59M | -1.2% |
| FY2014 | Mar 29, 2014 | $128.17M | +5.1% |
| FY2013 | Mar 30, 2013 | $121.92M | -12.1% |
| FY2012 | Mar 31, 2012 | $138.72M | -12.6% |
| FY2011 | Apr 2, 2011 | $158.69M | +25.4% |
| FY2010 | Apr 3, 2010 | $126.52M | +3.7% |
| FY2009 | Mar 28, 2009 | $122.03M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 26, 2026 | $102.88M | +18.6% |
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $84.57M | +2.3% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $4.29M | -95.7% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $94.78M | +7.6% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $86.75M | +7.2% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $82.63M | +19.9% |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $99.54M | +72.9% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $88.05M | +26.7% |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $80.91M | +38.8% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | $68.89M | -10.2% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $57.58M | -2.6% |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | $69.51M | +4.0% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $58.32M | -16.9% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $76.69M | +44.1% |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | $59.11M | +34.3% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $66.85M | +11.4% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $70.17M | +46.0% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | $53.21M | +101.4% |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $44.01M | +5888.0% |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $60.02M | -1.9% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $48.04M | -39.7% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | $26.42M | -18.5% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | $735.00K | -98.7% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $61.20M | -10.0% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $79.66M | +3.8% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $32.44M | +129.5% |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $54.77M | +2.1% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $67.96M | +20.8% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $76.77M | +49.5% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | $14.14M | -55.4% |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $53.64M | +44.0% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $56.27M | +141.5% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $51.35M | +10.5% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $31.71M | -17.4% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $37.26M | – |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $23.29M | -46.4% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $46.46M | – |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $38.40M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | -$35.30M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $43.49M | – |
See a number that looks wrong?